Dark

CYAD
Celyad Oncology - ADR
stock NASDAQ ADR

At Close

1/27/2023 3:55:30 PM EST

1.28USD-18.471%(-0.29)150,717

1.02Bid 1.56Ask 0.54Spread IEX

Pre-market

1/27/2023 9:28:30 AM EST

1.40USD-10.828%(-0.17)0

After-hours

1/24/2023 4:00:30 PM EST

1.58USD-1.863%(-0.03)0

Overview HistoricalMore

open chart

Market Cap

28.920M

Headquarters

Mont Saint Guibert, Brabant Wallon, Belgium

Industry

Biotechnology

BSTC ICLR CTLT XLV

CYAD Stats

Avg. Vol. 10 Day

12,868,537

Avg. Vol. 30 Day

4,749,705

Employees

Market Cap

28,920,264

Shares Out.

22,593,956

Float

13,577,612

On/Off Exchange

57%/43%

6 Month Beta

-0.30

1 Year Beta

-0.38

2 Year Beta

-0.36

3 Year Beta

-0.12

52 Week Low

0.46

52 Week High

3.65

SMA50

1.02

SMA200

1.39

1 Week

-34.02%

1 Month

+128.49%

3 Month

+17.43%

6 Month

-25.15%

1 Year

-61.91%

2 Year

-83.59%

5 Year

-97.31%

Jan 31, 2022

04:05PM EST Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced that the Company plans to participate virtually in the following conference in February 2022: GlobeNewswire Inc

Jan 11, 2022

06:58AM EST Wells Fargo Maintains Overweight on Celyad Oncology, Lowers Price Target to $11 Benzinga

Jan 10, 2022

01:40AM EST Celyad Oncology Provides 2022 View RTTNews

01:00AM EST Celyad Oncology Provides Outlook for 2022 GlobeNewswire Inc

Dec 31, 2021

01:00AM EST Information on the Total Number of Voting Rights and Shares GlobeNewswire Inc

More News

Profile

Celyad SA is a biopharmaceutical company. The company is engaged in stem cell-based therapies for the treatment of cardiovascular diseases. It is developing therapeutic therapies based on two distinct technology platforms in cardiology and oncology.

CYAD Stock Summary

Celyad Oncology - ADR (NASDAQ:CYAD) stock price today is $1.28, and today's volume is 150,717. CYAD is down -18.471% today. The 30 day average volume is 4,749,705. CYAD market cap is 28.920M with 22,593,956 shares outstanding.